A Novel, Stable, Aqueous Glucagon Formulation Using Ferulic Acid as an Excipient

BACKGROUND: Commercial glucagon is unstable due to aggregation and degradation. In closed-loop studies, it must be reconstituted frequently. For use in a portable pump for 3 days, a more stable preparation is required. At alkaline pH, curcumin inhibited glucagon aggregation. However, curcumin is not...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Diabetes Sci Technol
Hlavní autoři: Bakhtiani, Parkash A., Caputo, Nicholas, Castle, Jessica R., El Youssef, Joseph, Carroll, Julie M., David, Larry L., Roberts, Charles T., Ward, W. Kenneth
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2014
Témata:
Special Section: Glucagon Therapy
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4495527/
https://ncbi.nlm.nih.gov/pubmed/25253164
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1932296814552476
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky